Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.

The enterprise value of the transaction is SEK 500 million, with potential for an additional earnout of up to SEK 130 million. Up to SEK 100 million of the purchase price can be paid in Aspo shares.

Aspo is a Finnish conglomerate that specializes in demanding B-to-B customers. Aspo creates value by owning and developing business operations sustainably and in the long term. Aspo has businesses in 16 different countries, and it employs a total of approximately 700 professionals.

Read the client’s press release here.

Vinge’s team mainly consisted of Jonas Johansson, Linus Adolfsson, Tim Axell (M&A), Karl-Gustaw Tobola (Banking and Finance), Mario Saad (Corporate Commercial), Ebba Svenburg, Jonna Skog (Employment) Johan Cederblad, Lina Österberg (Environment), Elis Almark, Carla Zachariasson (IT & GDPR), Karolina Cohrs (Real Estate), Daniel Wendelsson, Sebastian Örndahl, Dagne Sabockis, Hilda Ivarsson (FDI, EU, Competition and Regulatory) and Emma Emsjö (Transaction Support Coordinator).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025